Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for OraSure Technologies, Inc. (OSUR : NSDQ)
 
 • Company Description   
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.

Number of Employees: 785

 
 • Price / Volume Information   
Yesterday's Closing Price: $5.48 Daily Weekly Monthly
20 Day Moving Average: 545,073 shares
Shares Outstanding: 72.46 (millions)
Market Capitalization: $397.06 (millions)
Beta: -0.26
52 Week High: $13.57
52 Week Low: $4.73
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -16.46% -5.92%
12 Week -29.38% -22.37%
Year To Date -36.94% -23.37%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
220 EAST FIRST STREET
-
BETHLEHEM,PA 18015
USA
ph: 610-882-1820
fax: 610-882-1830
investorinfo@orasure.com http://www.orasure.com
 
 • General Corporate Information   
Officers
Stephen S. Tang - Chief Executive Officer;President
Michele Miller - Chief Accounting Officer
Scott Gleason - Chief Financial Officer & Senior Vice President
MARA ASPINALL - Director
MICHAEL CELANO - Director

Peer Information
OraSure Technologies, Inc. (BJCT)
OraSure Technologies, Inc. (CADMQ)
OraSure Technologies, Inc. (APNO)
OraSure Technologies, Inc. (UPDC)
OraSure Technologies, Inc. (IMTIQ)
OraSure Technologies, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 68554V108
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
Share - Related Items
Shares Outstanding: 72.46
Most Recent Split Date: 4.00 (3.00:1)
Beta: -0.26
Market Capitalization: $397.06 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.08 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.18 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/02/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.09
Price/Cash Flow: -
Price / Sales: 1.64
EPS Growth
vs. Year Ago Period: -660.00%
vs. Previous Quarter: -100.00%
Sales Growth
vs. Year Ago Period: 15.58%
vs. Previous Quarter: 6.51%
ROE
03/31/22 - -12.15
12/31/21 - -5.83
09/30/21 - -2.70
ROA
03/31/22 - -10.29
12/31/21 - -5.00
09/30/21 - -2.35
Current Ratio
03/31/22 - 4.83
12/31/21 - 4.24
09/30/21 - 5.34
Quick Ratio
03/31/22 - 3.72
12/31/21 - 3.46
09/30/21 - 4.35
Operating Margin
03/31/22 - -19.25
12/31/21 - -9.84
09/30/21 - -4.61
Net Margin
03/31/22 - -19.25
12/31/21 - -9.84
09/30/21 - -4.61
Pre-Tax Margin
03/31/22 - -14.67
12/31/21 - -3.98
09/30/21 - 3.10
Book Value
03/31/22 - 5.04
12/31/21 - 5.28
09/30/21 - 5.39
Inventory Turnover
03/31/22 - 2.57
12/31/21 - 2.38
09/30/21 - 2.40
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.01
09/30/21 - 0.01
Debt-to-Capital
03/31/22 - 0.33
12/31/21 - 0.51
09/30/21 - 0.73
 

Powered by Zacks Investment Research ©